Click here to see the latest financial report.
Review of Activities, Achievements and Future Plans 2023.
Research work at St George’s University of London gradually returned to normal after the Coronavirus pandemic. Unfortunately, one of our key research assistants moved to Bath University to complete her PhD, but the team continued under the direct control of our Research Leader. A replacement started with us in April 2023.
As we mentioned last year, the Team had some encouraging results when pancreatic cells were treated with a combination of various drugs, including gemcitabine (the usual treatment) and research work in this field continues.
Donations have picked up from the period affected by covid but with continuing tight control of expenses, we feel able to continue this important research.
During this financial year, we participated in an appeal for funds to support research at Oxford University. The donations received are restricted to research being carried out by a specific team and were made in memory of Richard Nevill, who was undergoing private treatment for pancreatic cancer administered by this team. Unfortunately, he died during the appeal, but the Oxford team will continue their research funded by the donations made in Richard’s name.
See previous financial reports:
